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Formaldehyde kinetics and bacteriology in dialyzers. The kinetics of
formaldehyde washout in new and reused dialyzers with 2% (w/v) and
4% formaldehyde solution was studied. Using a standard method of
rinsing, the concentration of formaldehyde decreases exponentially, but
the rate of decrease and the steady-state level depends on the type of
dialyzer. The residual quantity of formaldehyde using a 4% solution is
more than twice that seen with a 2% solution in similar dialyzers.
Bacteriological tests on water-adapted, formaldehyde-resistant orga-
nisms indicate that a significant proportion of these organisms can
survive a 4-hr incubation with 4% formaldehyde at 20°C. However,
increasing the temperature of incubation to 40°C or the addition of
ethanol up to 8% (vlv) improved the bacteriological efficacy of formal-
dehyde. Under these conditions, a 1% formaldehyde solution allows
eradication of all organisms tested. Similar results were observed in
multiple-use dialyzers inoculated with the same organisms. There was
no effect of incubation at 40°C on the in vitro clearance determinations
of new and reused dialyzers.
Cinétique du formaldehyde et bactérlologie dans les dialyseurs La
cinétique de l'Climination du formaldehyde dans les dialyseurs neufs et
réutilisCs a etc étudiée avec des solutions de formaldehyde a 2% (w/v)
et a 4%. Utilisant une mCthode standard de rincage, Ia concentration de
formaldehyde diminue de facon exponentielle, mais le taux de diminu-
tion et le niveau d'equiibre dependent du type de dialyseur. La quantité
rCsiduelle de Ia solution de formaldehyde a 4% est plus de 2 fois
supérieure a celle observée avec Ia solution a 2% dans des dialyseurs
identiques. Des tests bactCriologiques sur des organismes adaptes a
l'eau et "formaldehyde résistants" indiquent qu'une proportion signif-
icative de ces organismes peut survivre a une incubation de 4 heures
avec la solution a 4% de formaldehyde a 20°C. Cependant, l'augmenta-
tion de Ia temperature d'incubation 40°C ou l'addition d'étanoljusqu'a
8% (v/v) améliore l'efficacité bacteriologique du formaldehyde. Dans
ces conditions, une solution de formaldehyde a 1% permet l'éradication
de tous les organismes testes. Des rdsultats semblables ont eté observes
avec des dialyseurs a usage multiple inoculés avec les mCmes
organismes. L'incubation 40°C n'a eu aucun effet sur les dCtermina-
tions de la clearance in vitro des dialyseurs neufs et réutilisés.
Reuse of dialyzers has been associated with significant sav-
ings in the total cost of providing hemodialysis services [1, 21.
Several reports have also documented improved biocompat-
ibility and a decrease in the inter- and intradialytic morbidity of
patients reusing cuprophane dialyzers [3—61. In addition, there
is suggestive evidence that reuse may be associated with a
Received for publication February 5, 1985,
and in revised form May 21, 1985
© 1985 by the International Society of Nephrology
decrease in patient mortality [7]. These factors have led to an
increase in the number of patients reusing dialyzers, so that by
1982, 51% of patients were reusing dialyzers [8].
The primary disinfectant used in the process of dialyzer reuse
has been formaldehyde, usually at a concentration of 2% weight
by volume (w/v). Initial concern about the use of formaldehyde
centered around the development of anti-N-like antibodies
[9—12], increased hemolysis [13—15], and renal allograft wastage
[161. An increased incidence of nasal squamous cell carcinoma
in mice exposed to concentrated formaldehyde vapors has been
reported also [17]. These adverse effects are generally related to
the residual levels and the cumulative dose of formaldehyde
received by patients [10, 14].
More recently, the disinfectant capacity of 2% formaldehyde
has been questioned following clinical infections by non-tuber-
cular mycobacteria organisms, which may have been implicated
in the mortality of some patients in two large dialysis units [18,
19]. These events have prompted several agencies to recom-
mend increasing the concentration of formaldehyde used in the
reprocessing of dialyzers to 4% w/v [18, 20]. However, no
studies of residual concentrations have been published. These
concerns prompted us to study residual formaldehyde levels
and potential cumulative formaldehyde dosage in different
dialyzers at various initial concentrations of formaldehyde, as
well as to determine the bacteriological efficacy of different
formaldehyde concentrations and explore methods that may
enhance this efficacy.
Methods
Residual formaldehyde level
Three types of hollow-fiber dialyzers were selected: cupro-
phane (PCS-A, Erika Inc., Rockleigh, New Jersey, USA),
cellulose acetate (CD4000, Cordis Dow, Miami Lakes, Florida,
USA) and polymethylmethacrylate (B2-150, Toray Co., Tokyo,
Japan). dialyzers were studied prior to their in vivo use and
following their third clinical use. All dialyzers had the same
fiber potting compound made from polyurethane. Each dialyzer
was filled (blood and dialysate compartment) with 2.0 0.1 or
4.0 0.1% formaldehyde solution and kept at room tempera-
ture for at least 48 hr. Following this period, dialyzers were
rinsed in the usual fashion: an arterial line was primed with
saline and connected to the arterial and venous end of the
dialyzer blood compartment. The blood compartment volume
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was recirculated in a closed ioop through a calibrated pump at
300 mi/mm. Single-pass dialysate flow was begun concomitantly
in the dialysate compartment at 500 ml/min (Fig. 1, region A).
Six-milliliter aliquots were drawn from the blood compartment
every 5 mm for 30 mm and assayed for formaldehyde. After 30
mm, the dialysate flow was interrupted, but recirculation was
maintained through the blood compartment (Fig. 1, region B).
The extent of rebound of formaldehyde levels was monitored
for the next hr by measuring aliquots from the blood compart-
ment at 10-mm intervals. This sequence of procedures was
repeated once again (respectively, Fig. 1, regions C and D).
Cumulative formaldehyde dose
In another series of experiments, hollow-fiber dialyzers
packed with either 2 or 4% formaldehyde were rinsed in a
countercurrent fashion for 30 mm as described above and tested
to be negative for formaldehyde by the modified Schiff reagent
[21]. The dialysate and blood lines were then connected to-
gether and the volume in both compartments recirculated
through a 9.5-liter vessel containing reverse osmosis water at
room temperature for 24 hr. The change in concentration of
formaldehyde in the large container was determined at inter-
vals.
Formaldehyde measurements
Formaldehyde was measured spectrophotometrically using
the acetyl-acetone method developed by Nash [22]: reaction
between formaldehyde and 0.1 M acetone at pH 6.0 yields
diacetytoluidine, which is yellow and has a peak absorption at
415 nm. The method is linear in the range of 0.1 to 50 mg/liter
(ppm) of formaldehyde. Samples that were above this range
were appropriately diluted.
Bacteriological testing
The cidal activity of formaldehyde was tested against water-
grown cultures of bacteria originally collected from the water
treatment facilities of dialysis units. These organisms are "wa-
ter-adapted," naturally-occurring organisms that can multiply
even in treated water or in water that had undergone distillation
or reverse osmosis because of their ability to utilize trace
quantities of organic carbon and nitrogen as nutrient energy
sources [18, 23—25]. They are also more resistant to disinfec-
tants than culture-media grown organisms [23—25].
The first two inoculants were water cultures of acid-fast
rod-shaped bacterial isolates obtained from the Hospital Infec-
tions Group of the Center for Disease Control (CDC, Atlanta,
Georgia, USA). The first, BR-MCLO (Baton Rouge-
mycobacterium chelonei-like organism) was originally collected
during the CDC's investigation of the outbreak of indolent
infections in two dialysis units [19]. The collected population
was highly resistant to 2% formaldehyde [18]. At the time of
specimen collection, the water also contained approximately
0.5 mg/liter chloramine and thus this isolate was a selected
population particularly resistant to disinfection and steriliza-
tion. The second acid-fast organism (M-21) was also obtained
from the CDC and water-adapted organisms were grown simi-
larly. To facilitate further references to these organisms, they
are labeled "formaldehyde-resistant organisms" FRO-l (BR-
MCLO) and FRO-2 (M-21).
Two other bacterial populations were tested. FRO-3 was a
water-adapted subculture of a specimen found to contain the
most formaldehyde-resistant organisms during a survey of 20
different dialysis water treatment systems. FRO-3 is a gram-
negative organism which forms pink-pigmented colonies when
grown on a culture media, and has been identified as being
primarily a Pseudomonas species (Pseudomonas mesophilica).
Clinical infections in dialysis patients have recently been re-
ported with organisms having similar characteristics [26, 27].
FRO-4 is a mixed population of these gram-negative, water-
adapted organisms and acid-fast bacteria produced by culturing
in water the survivors of a pooled specimen collected from the
purified water supply (that is, after it has undergone reverse
osmosis) of 30 dialysis units. Subsequently, these isolates were
incubated further in a 2% formaldehyde solution at 20°C for 24
hr and surviving organisms subcultured in sterile carbon-filtered
reverse-osmosis water. The water cultures of FRO-l and
FRO-2 were 3 months old at the time of disinfectant exposure,
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Fig. 1. Residual concentration of formaldehyde in the blood compart-
ment with (Regions A and C) and without (Regions B and D) dialysate
flow in cuprophane (CU) dialyzers. Top panel shows new cuprophane
dialyzers and the lower panel, cuprophane dialyzers after third use.
Symbols are: 0, 4% formaldehyde; •, 2% formaldehyde.
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Table 1. Experimental design
Factor Level
Formaldehyde concentration, w/v 1% 2% 4%
Ethanol concentration, v/yb 0% 4% 8%
Temperature 20°C 30°C 40°C
a These formaldehyde concentrations are diluted from concentrated
37% stock formaldehyde solutions. These solutions contain approxi-
mately 15% methanol (w/v). Thus, a nominal 4% formaldehyde solution
contains in addition 2.0% methanol (w/v).
b The ethanol concentration is the final concentration of ethanol in
the formaldehyde solution.
whereas the water cultures of FRO-3 and FRO-4 were 1 month
old.
The volume of inoculant required to yield io to l0 colony-
forming unit (CFU)/ml challenge was determined by prelimi-
nary colony counts of the parent culture. This volume of
inoculant was then added to sterile culture bottles with leak-
proof caps which contained different formaldehyde and ethanol
concentrations and incubated at three different temperatures
according to the three-factor design experiment outlined in
Table 1.
Twenty-seven cultures (3 x 3 x 3) were performed for each
organism tested, for a total of 108 cultures. All cultures were
kept at the specified conditions for 4 hr, then filtered over 0.45
filter, rinsed with sterile water to remove any residual
formaldehyde or ethanol, and the membranes aseptically re-
trieved, placed on nutrient pads (Nalgene, Rochester, New
York, USA) and incubated at 30°C for 7 days. Colony counts
were done by visual counting of the number of colonies at X 35
magnification.
Multiple-use dialyzers, no longer suitable for patients' use
because their fiber bundle volume had decreased by more than
20% of their initial value, were also used for bacteriological
testing. A volume of bacterial inoculant required to yield — l0
CFU/ml was introduced into sterile water-filled blood compart-
ments of these dialyzers via the arterial line, and the blood
compartment recirculated in a closed loop via a pump at 300
mlimin for 15 mm. Large volumes of formaldehyde solutions, at
concentrations of 0.5, 1, 2, and 4% were circulated through the
dialysate compartment in a countercurrent fashion. After 10
mm, formaldehyde concentrations in the blood and dialysate
compartment were similar (± 0.1%). These dialyzers were then
incubated at room temperature or 40 1°C for 24 hr. Following
incubation, the formaldehyde was flushed out by perfusing the
dialysate compartment with large volumes of water and displac-
ing the blood compartment volume by sterile air. Aliquots of
1.0, 0.1, and 0.01 ml were filtered over 0.45 .t filters, rinsed with
sterile water to remove any residual formaldehyde, and incu-
bated as discussed above.
Bacterial kill curves
Because of the significant survival of these organisms after 4
hr of incubation at room temperature and 2% formaldehyde,
several of these organisms were exposed to disinfectants under
similar conditions, but the incubation time was prolonged to 24
or 48 hr and their survival determined at intervals. From these
so-called "kill curves," the predicted number of colonies that
may persist in the 60 ml volume of the dialyzer blood compart-
Table 2. Blood compartment residual formaldehyde level, mg/liter
New dialyzers
29o Formaldehyde 4% Formaldehyde
Cupro-
phane
Cellulose
Acetate
Cupro-
PMMA phane
Cellulose
Acetate PMMA
A
B
C
D
5
50
1
7
11
34
1
13
0.5 3
20 87
0.5 1
20 12
Reused dialyzers
19
82
3
29
2
52
1
45
A
B
C
D
6
55
3
13
2.5
45
1
22
1 9
15 85
1 3
14 16
4
82
1.5
37
2
47
2
43
ment with an initial inoculant of 200 CFU/ml and incubation at
20°C for 24 hr was calculated.
In vitro clearance
In vitro clearance determination of multiple-use dialyzers
incubated with different concentrations of formaldehyde (1, 2,
and 4%) and at 20 or 40°C were determined using aqueous
solutions of sodium chloride and vitamin B 12 in a standard
assay. Two dialyzers were used for each test condition. The
concentration of sodium chloride was determined by measuring
the conductivity of the solution, and the concentration of
vitamin B 12 was determined spectrophotometrically. Accuracy
of the determinations was checked by mass balance calcula-
tions.
Results
Formaldehyde kinetics
The diffusion of formaldehyde from the blood compartment
appears to be rapid during the initial countercurrent rinse of the
dialyzer with single-pass dialysate flow, as shown in Figure 1
for new cuprophane (CU) membrane dialyzers. There is a rapid
exponential decay of formaldehyde concentration; by 20 mm,
the concentration in the blood compartment is below 10 mg/liter
and at 30 miii is s S mg/liter. There appears to be no significant
difference in the time to achieve this level between dialyzers
packed with 2 or 4% formaldehyde. However, discontinuation
of dialysate flow (Fig. 1, region B), while maintaining recircula-
tion in the blood compartment, leads to rapid increase in
formaldehyde concentration in the blood compartment, up to 50
mg/liter for dialyzers initially packed with 2% formaldehyde and
87 mg/liter for dialyzers packed with 4% formaldehyde. Note,
however, that for dialyzers stored in 4% formaldehyde, the
rebound level had not reached steady state and was still rising.
Reinitiation of dialysate flow led to a rapid decrease in the
formaldehyde concentration within a few mm, reaching levels
1 mg/liter and remaining constant at this level (Fig. 1, region
C). However, discontinuation of the dialysate led to further
rebound in formaldehyde levels, rising to 7 mg/liter with dialyz-
ers packed in 2% formaldehyde and 12 mg/liter in dialyzers
packed with 45% formaldehyde (Table 2).
Similar results are seen with cuprophane dialyzers following
their third in vivo use (Fig. 1). The decrease in formaldehyde
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Fig. 2. Residual concentration of formaldehyde in the blood compart-
ment with (Regions A and C) and without (Regions B and D) dialysate
flow in cellulose actate (CA) dialyzers. Symbols and definitions same as
Fig. 1.
concentration during the initial rinse (Fig. 1, region A) is similar
to that seen with new dialyzers, with levels at 30 mm reaching
only 6 mg/liter and 9 mg/liter for dialyzers packed in 2 and 4%
formaldehyde, respectively. Rebound formaldehyde level when
dialysate flow is discontinued is also approximately the same
for new and reused dialyzers, with levels reaching 55 and 85
mg/liter for reused cuprophane dialyzers packed in 2 and 4%
formaldehyde, respectively. Levels of formaldehyde at the end
of region C and region D are shown in Table 2 and indicate that
residual levels of formaldehyde during the rinse procedure
(region C) is somewhat higher than those seen with new
dialyzers, but that the rebound seen in region D remains
approximately the same.
Significant differences in formaldehyde levels were observed
between new and reused cellulose acetate (CA) dialyzers,
particularly during the initial rinse procedure (Fig. 2). Thus,
alter 30 mm of countercurrent flow in new dialyzers, the
residual formaldehyde concentration in the blood compartment
was 11 mg/liter and 19 mg/liter for dialyzers packed with 2 and
4% formaldehyde, respectively (Fig. 2, region A). However,
alter the third use of these dialyzers, the concentration of
formaldehyde decreased more quickly than with new dialyzers.
Thus, at the end of 20 mm of rinse, the residual formaldehyde
was less than 10 mg/liter for these dialyzers and less than 5
mg/liter at the end of 30 mm of rinse. Rebound levels, however,
remained high and reached 34 and 82 mg/liter at the end of 1 hr
after dialysate flow was discontinued in new dialyzers (Fig. 2
and Table 2), and were not significantly different from levels
seen with reused CA dialyzers.
Polymethylmethacrylate (PMMA) dialyzers achieved the
lowest concentration of formaldehyde at the end of the rinse
cycle. Thus, the level of formaldehyde in PMMA dialyzers
packed with 2% formaldehyde was as low as 0.5 mg/liter, and 1
mg/liter in dialyzers packed with 4% formaldehyde. Note also
that these low levels were achieved earlier than in the other
dialyzers, and, by 15 mm, the concentration of formaldehyde in
all PMMA dialyzers was below 5 mg/liter. Similarly, rebound of
formaldehyde alter discontinuation of dialysate flow was con-
siderably lower with PMMA than with the other types of
dialyzers (Table 2). However, even for these dialyzers, steady-
state values were not achieved at the end of 1 hr of no dialysate
flow in dialyzers packed with 4% formaldehyde.
The total quantity of residual formaldehyde following a
30-mm rinse was estimated by determining the steady-state
concentration of formaldehyde in equilibrium with a large
volume of water, as shown schematically in Figure 3 for
cellulose acetate dialyzers. This steady state was achieved
within 8 hr for dialyzers filled with 2% formaldehyde solution.
The results are shown in Table 3 for all dialyzers packed with
either 2 or 4% formaldehyde. It is seen that approximately 63
mg of formaldehyde remains in the new cuprophane dialyzers
alter 30 mm of rinse and achieving a negative Schiff test, and
this increased to 150 mg for dialyzers packed with 4% formal-
dehyde. As expected, cellulose acetate dialyzers contained
higher amounts, whereas PMMA dialyzers contained the least
amount of formaldehyde alter the 30-mm rinse.
Experiments in which segments of hollow fibers and
polyurethane blocks were incubated for 48 hr with 4% formal-
dehyde, rinsed with water until the effluent was formaldehyde
free by the Schiff test, and incubated in a small (3 cc) volume
of water did not show any rebound in the concentration of
formaldehyde. However, incubation of a segment of the potting
compound from a dialyzer under the same conditions did show
a rebound in the level of formaldehyde (results not shown),
indicating that the residual formaldehyde resides primarily at
the interface between the hollow fiber and potting compound.
This was confirmed by an intense coloration seen around the
fibers when the potting compound was stained with Schiff's
solution.
Bacteriological tests
Figure 4 shows the percentage of survival of the four orga-
nisms at different formaldehyde concentrations under standard
conditions (20°C, no ethanol added). These organisms displayed
different resistances to the disinfecting power of formaldehyde,
with the highest survival percentage (at 4% formaldehyde)
shown by the gram-negative FRO-3 organisms. All organisms
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Fig. 4. The percentage of survivors for each of four formaldehyde-
resistant organisms incubated for 4 hr at 20°C with 1, 2, and 4%
formaldehyde and no ethanol. Symbols are: E1, FRO-1; , FRO-2; a
FRO-3;, FRO-4.
1 2
Fig. 5. Average survival percentage of all four organisms with different
ethanol and formaldehyde concentrations incubated for 4 hr at 20°C.
Symbols are: L1, no alcohol; , 4% alcohol; , 8% alcohol.
Formaldehyde concentration, %
Fig. 6. Average survival percentage of all four organisms incubated with
1, 2, and 4% formaldehyde solutions at 20, 30, and 40°C. No ethanol
was added in this experiment. Symbols are: , 20°C;, 30°C; —*—, 40°C
(no growth).
cidal activity of formaldehyde for FRO-3 incubated with 2%
formaldehyde (Fig. 7). Thus, it is seen that there is no detect-
able growth at 40°C. At 30°C, there was no growth in the
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Table 3. Residual amount of formaldehyde after 30-mm rinse, mg
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showed significant survival with 2% formaldehyde at 20°C at the
end of 4 and 24 hr of incubation.
To display the effects of ethanol, temperature, and varying
formaldehyde concentrations, the average survival percentage
of all four organisms incubated at 20°C with different formalde-
hyde and ethanol concentrations is shown in Figure 5. It is seen
that the addition of ethanol significantly improves the bacteri-
ological activity of formaldehyde, with the reduction of average
survival (at 2% formaldehyde) from 11.3% when no ethanol is
added to 4.1% with the addition of 8% ethanol v/v.
The effects of temperature of the incubation are shown in
Figure 6. It can be seen that incubation of the organisms at 40°C
leads to effective kffling of all organisms, even when incubated
with 1% formaldehyde and without the addition of any ethanol.
The combined effects of temperature and ethanol increases the
0
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Factor
Survival
Variance F P
Temperature (A)
Alcohol (B)
Formaldehyde (C)
A x B
A x C
BxC
Organism
Error
417.6
138.7
105.5
61.5
36.2
10.6
120.6
12.3
33.9
11.3
8.6
5.0
2.9
.9
—
—
0.01
0.01
0.01
0.01
0,05
NS
—
—
samples incubated with 8% ethanol, but 6.1% of the initial
inoculant survived at 4% ethanol.
Multivariate analysis [28] of the effects of formaldehyde,
ethanol, and temperature of incubation on organism survival
and blocked by organism (Table 4) indicates that the survival of
the organisms in this model is most sensitive to the effects of
temperature of incubation and least sensitive to the formalde-
hyde concentrations. (Note, however, that 0% formaldehyde
was not tested in this model).
The kill curves for the mixture of acid-fast and gram-negative
organisms (FRO-4) is shown in Figure 8. Although there was no
detectable growth for any of the formaldehyde-ethanol combi-
nations when incubated at 20°C for 48 hr, there was significant
growth at 24 hr for 1 and 2% formaldehyde concentrations, but
not for the 4% formaldehyde concentration. The addition of 8%
ethanol significantly increased the cidal activity of 2% formal-
dehyde and by 24 hr, there was no detectable growth.
Results of bacteriological testing in multiple-use dialyzers
confirmed the dramatic effects of temperature of incubation.
Although with room temperature incubation the number of
surviving organisms decreased as concentration of formalde-
hyde increased, there were still more than 40,000 surviving
FRO-1 organisms and more than 1000 FRO-3 organisms in these
dialyzers at the end of 24 hr of incubation with 4% formalde-
Time, hr
Fig. 8. Kill curves for FRO-4 organisms at 20°C with different formal-
dehyde and ethanol concentrations. Note the zero growth scale is
shifted upward. Symbols are: 0, 1% formaldehyde, no ethanol; , 1%
formaldehyde, 8% ethanol; •, 2% formaldehyde, no ethanol; A, 2%
formaldehyde, 8% ethanol; LI, 4% formaldehyde, no ethanol.
hyde (Table 5). Two new organisms, highly resistant to disin-
fection, and obtained from the Hospital Infection Group of the
Center for Disease Control (FRO-5, a mycobacterium cheloni-
like organism and FRO-6, a water-adapted formaldehyde-resis-
tant Pseudomonas mesophilica species), were also tested in the
same manner and with similar results. However, there was no
growth detected in any of the dialyzers incubated at 40°C with
1, 2, or 4% formaldehyde. Incubation at 40°C of similarly reused
dialyzers with 0.5% formaldehyde also revealed no growth in
any of these dialyzers (Table 5).
Because the inoculant used in these dialyzers was i05
CFU/ml, it may be argued that the size of the inoculants
exceeds the number of organisms likely to be present in dialysis
systems. Table 6 indicates the expected number of surviving
organisms for an inoculant of 200 CFU/ml in a 60-mi dialyzer
blood compartment. It can be seen that a substantial number of
organisms can remain viable in dialyzers incubated for 24 hr at
20°C with 2 and even at 4% formaldehyde; increasing the
incubation temperature to 40°C achieves sterility with all orga-
nisms tested, even at formaldehyde concentrations as low as
0.5%.
Results of in vitro clearance of sodium chloride and vitamin
B 12 in dialyzers incubated with different formaldehyde concen-
trations and at temperatures up to 40°C were not significantly
different from each other and were only a function of residual
fiber volume.
Discussion
The results shown above indicate that different dialyzers
have different residual formaldehyde levels or "sinks," and that
the extent of these sinks, as indicated by the level of rebound,
is significantly higher with 4% formaldehyde. In vitro bacterio-
logical testing indicates that alternatives to the use of increasing
concentrations of formaldehyde exist, most important, increas-
ing the temperature of incubation, adding ethanol, or both.
The nature of the formaldehyde sink is not clear at present,
although our results indicate that it is primarily in the gel
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Fig. 7. Combined effect of temperature of incubation and ethanol on
FRO-3 organisms incubated with 2% formaldehyde. Symbols are: 0,
no ethanol; , 4% ethanol; , 8% ethanol. Absence of symbol means
no growth.
Table 4. Analysis of variance
Temperature, °C
0 10 20 30 40 50
942 Hakim et a!
Table 5. Number of surviving organisms (CFU/ml) in multiple-use dialyzers
Organisms
(Initial inoculant)
20°C Incubation 40°C Incubation
Formaldehyde concentration Formaldehyde concentration
1% 2% 4% 0.5% 1% 2% 4%
FRO-l (23 x 106 CFU)
FRO-3 (9 x lO CFU)
FRO-5 (38 x 106 CFU)
FRO-6 (3.2 x l0 CFU)
TNTCa
38,700
TNTC
TNTC
900,000
22,000
14,300
250,000
40,000
1,040
1,200
50,100
0
0
0
0
0 0
0 0
0 0
0 0
0
0
0
0
a TNTC, Too numerous to count.
Table 6. Predicted number of survivors in small inoculant (200
CFU/ml) in dialyzers (24-hr incubation at 20°C)
2% formaldehyde 4% formaldehyde
FRO-l 470 21
FRO-3 293 14
FRO-5 5 0.4
FRO-6 9375 1878
No survivors are predicted for incubation at 40°C for all formalde-
hyde concentrations tested (0.5, 1, 2, and 4%).
structure at the interface between polyurethane potting com-
pound and the hollow fibers. The magnitude of these sinks
appears to be dependent on the type of dialyzers. However,
since there was no detectable rebound with either segments of
hollow fibers or solid blocks of polyurethane, it is likely that the
difference between different types of dialyzers is due to the
extent of the gel layer around the hollow fibers, which in turn is
due to differences in the expansion coefficient between the
hollow fiber materials and polyurethane, as well as the temper-
ature and length of the curing process.
During rinsing of the dialyzer, the concentration of formal-
dehyde in the blood compartment will be determined by the
diffusion of formaldehyde into the dialysate compartment, as
well as by the rate of diffusion of formaldehyde from these
pen-fiber regions (leaching rate). These relationships can be
represented by the equation below [29]:
where
cF = c0t+ — eK V1
CF = Concentration of formaldehyde at time t
C0 = Initial concentration of formaldehyde (mg/liter)K = Formaldehyde clearance (liter/mm)V = Volume of distribution (liter)
L = Leaching rate (mg/mm)
When the clearance of formaldehyde is significantly higher
than the leaching rate, as occurs during the rinsing procedure
(region A), the first term of the equation will predominate and
an exponential fall of formaldehyde concentration will occur.
At longer times, the first term of the equation approaches zero
and the steady-state residual concentration of formaldehyde is
equal to LIK or the ratio of the rate of diffusion from the sinks
to its clearance. Since clearance is constant, the steady state is
proportional to the rate of leaching of formaldehyde from these
sinks.
When dialysate flow is stopped, clearance of formaldehyde
decreases to zero and the concentration of formaldehyde in the
blood compartment increases until equilibration with the con-
centration in the sink. Therefore, the magnitude of the rebound
will be proportional to the concentration of formaldehyde in
these sinks. An estimation of the magnitude of these sinks can
be obtained from the level of rebound, as well as from the
long-term, large-volume equilibrations shown in Figure 3 and
Table 3. Both these experiments indicate that the retention of
formaldehyde in these sinks is not linearly related to the initial
concentration, and the amount of residual formaldehyde with
4% formaldehyde is more than twice the amount seen with 2%
formaldehyde. It should be recalled, however, that these cumu-
lative doses of formaldehyde represent an upper limit of form-
aldehyde that is potentially available for infusion into the
patient. It is likely that a major portion of this formaldehyde is
excreted via the single-pass dialysate during clinical dialysis.
Reuse of dialyzers does not seem to affect the rebound of
formaldehyde, suggesting that the pen-fiber sinks remain un-
changed with reuse. However, any protein or cellular debris
that may be deposited inside these hollow fibers would be
expected to act as a small-volume, low-concentration sink and
will result in a slightly higher steady-state residual formalde-
hyde level at the end of the rinse cycle.
The bacteriocidal effectiveness of 4% formaldehyde solution
is superior to the 2% solution. However, our results indicate
that increasing the temperature of incubation to 40°C improves
(1) the bacteriocidal activity of formaldehyde substantially more,
and may allow the use of lower formaldehyde concentrations in
the reuse process. The effect of temperature of incubation is
probably due to several factors. Formaldehyde in aqueous
solution consists primarily of methylene glycol, the hydration
product of formaldehyde, as well as polymeric forms of meth-
ylene glycol (paraformaldehyde) according to the reaction [30]:
CH2O + H20 HO. CH2O . H
(n) HO. CH2O.H HO. (CH2O) .H + H20
(2)
(3)
The equilibrium constant of the reaction shown in equation (2)
is approximately 4 x i0 at room temperature and only a small
fraction of an aqueous solution exists as free formaldehyde, the
active bacteriocidal agent. At higher temperatures, the equilib-
rium of the reaction increases exponentially [30] and more of
the formaldehyde exists in the non-hydrated state, leading to
improved bacteriological activity. Increased metabolic activity
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of the organisms at higher temperatures may also lead to
increased incorporation of the formaldehyde in the cell wall,
contributing to their destruction.
The increased cidal activity of formaldehyde with the addi-
tion of ethanol is likely to be related to the fatty acid content of
the cell wall of mycobacteria and many of the gram-negative
organisms [31]. Colonies of mycobacteria grown on agar are
difficult to obtain in water suspension because of their hydro-
phobic cell wall. The detergent effects of simple alcohol may
thus contribute to the increased contact between formaldehyde
monomers and the bacterial cell wall.
In summary, these findings suggest that increasing formalde-
hyde concentration to 4% as suggested by the CDC and NKF
may be associated with a significant increase in residual form-
aldehyde quantity that is potentially available for infusion into
the patient. Although the major portion of this formaldehyde is
removed through the dialysate, it is likely that the amount that
may be incorporated into or reside in the blood compartment
will be proportional to the total quantity of available formalde-
hyde.
On the other hand, bacteriological testing indicates that at
room temperature, the use of 4% formaldehyde affords a margin
of safety since the kill curve indicates very few of these
formaldehyde-resistant organisms survived at 24 hr, whereas
with 2% formaldehyde, there were still survivors. Incubation at
40°C, however, shows complete eradication of all organisms
tested, even in multiple-use dialyzers using 0.5% formaldehyde.
These conditions do not adversely affect the in vitro clearance
of small or middle molecule substances. It appears, therefore,
that the solution to the concern of high residual formaldehyde
and the potential for clinical infections with the use of lesser
concentration of formaldehyde may exist in the incubation of
these dialyzers at higher than room temperature and, possibly,
the addition of ethanol to lower the concentration of formalde-
hyde.
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